Jeffrey Chodakewitz
Director, Tetraphase Pharmaceuticals (United States).
Companies
- Praxis Precision Medicines, Inc.Board member Apr 15, 2021 to now1
- SchrödingerBoard member May 4, 2020 to now2
- Adicet Bio, Inc.Board member Aug 15, 2018 to now3
- Tetraphase Pharmaceuticals (United States)Board member Jun 17, 2014 to Jun 11, 20194
- Vertex PharmaceuticalsSVP GMDA, CMO Jul 17, 2014 to Apr 2, 20185
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Schrödinger SDGR25,388 shares6$656.9K at $25.88Jun 22, 2026- Praxis Precision Medicines, Inc. PRAX1,371 shares7$340.3K at $248.24Jun 10, 2026
- Adicet Bio, Inc. ACET17,700 shares8$80.9K at $4.57Jun 11, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 22, 2026Granted 8,141 shares of Schrödinger6
- Jun 10, 2026Granted 1,371 shares of Praxis Precision Medicines, Inc.7
- Jun 18, 2025Granted 5,997 shares of Schrödinger9
- Jun 11, 2025Granted 5,900 shares of Adicet Bio, Inc.8
- Jun 18, 2024Granted 5,000 shares of Schrödinger10
- Jun 5, 2024Granted 5,900 shares of Adicet Bio, Inc.11
- Jun 15, 2023Granted 6,250 shares of Schrödinger12
- Jun 1, 2023Granted 5,900 shares of Adicet Bio, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARSchrödinger, Board member
- 3SEC EDGARAdicet Bio, Inc., Board member
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jun 20, 2025
- 10SEC EDGARForm 4 filed Jun 20, 2024
- 11SEC EDGARForm 4 filed Jun 7, 2024
- 12SEC EDGARForm 4 filed Jun 16, 2023
- 13SEC EDGARForm 4 filed Jun 2, 2023